Alborz Nano-drug Technology Company

Alborz Nanodrug Technology is an Iranian biotechnology company specializing in the development and production of advanced nanomedicines and targeted drug delivery systems. The company focuses on high-tech pharmaceutical products, particularly in the field of oncology, utilizing nanotechnology to improve the efficacy and reduce the toxicity of conventional chemotherapeutic agents. Their flagship product, Paclinab, is a nanoparticle albumin-bound formulation of paclitaxel, positioning the company as a key regional player in complex generic biosimilars and nano-formulations. Alborz Nanodrug operates state-of-the-art manufacturing facilities that comply with international GMP standards to serve both domestic and international markets.